Rockwell Medical, Inc.

NasdaqCM:RMTI Stock Report

Market Cap: US$88.7m

Rockwell Medical Future Growth

Future criteria checks 4/6

Rockwell Medical is forecast to grow earnings and revenue by 169.8% and 9.5% per annum respectively while EPS is expected to grow by 167.9% per annum.

Key information

169.8%

Earnings growth rate

167.9%

EPS growth rate

Medical Equipment earnings growth17.7%
Revenue growth rate9.5%
Future return on equityn/a
Analyst coverage

Low

Last updated12 Aug 2024

Recent future growth updates

Rockwell Medical, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates

Aug 11
Rockwell Medical, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates

Recent updates

Rockwell Medical, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates

Aug 11
Rockwell Medical, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates

Rockwell Medical, Inc.'s (NASDAQ:RMTI) Subdued P/S Might Signal An Opportunity

Jul 12
Rockwell Medical, Inc.'s (NASDAQ:RMTI) Subdued P/S Might Signal An Opportunity

Does Rockwell Medical (NASDAQ:RMTI) Have A Healthy Balance Sheet?

May 08
Does Rockwell Medical (NASDAQ:RMTI) Have A Healthy Balance Sheet?

Is Rockwell Medical (NASDAQ:RMTI) A Risky Investment?

Feb 06
Is Rockwell Medical (NASDAQ:RMTI) A Risky Investment?

Rockwell Medical, Inc. (NASDAQ:RMTI) Doing What It Can To Lift Shares

Dec 25
Rockwell Medical, Inc. (NASDAQ:RMTI) Doing What It Can To Lift Shares

Is Rockwell Medical (NASDAQ:RMTI) Using Too Much Debt?

Oct 11
Is Rockwell Medical (NASDAQ:RMTI) Using Too Much Debt?

Is Rockwell Medical (NASDAQ:RMTI) Weighed On By Its Debt Load?

Jun 02
Is Rockwell Medical (NASDAQ:RMTI) Weighed On By Its Debt Load?

Is There Now An Opportunity In Rockwell Medical, Inc. (NASDAQ:RMTI)?

Oct 25
Is There Now An Opportunity In Rockwell Medical, Inc. (NASDAQ:RMTI)?

An Intrinsic Calculation For Rockwell Medical, Inc. (NASDAQ:RMTI) Suggests It's 46% Undervalued

Sep 02
An Intrinsic Calculation For Rockwell Medical, Inc. (NASDAQ:RMTI) Suggests It's 46% Undervalued

Rockwell Medical Q2 Earnings Preview

Aug 12

Rockwell Medical: Triferic Remains Key Despite Sluggish Growth Profile

Mar 02

Rockwell Medical: Down But By No Means Out

Oct 05

Rockwell Medical pops 6% on licensing deal for Triferic AVNU in Turkey

Jun 08

Health Check: How Prudently Does Rockwell Medical (NASDAQ:RMTI) Use Debt?

Mar 08
Health Check: How Prudently Does Rockwell Medical (NASDAQ:RMTI) Use Debt?

Some Rockwell Medical, Inc. (NASDAQ:RMTI) Analysts Just Made A Major Cut To Next Year's Estimates

Feb 10
Some Rockwell Medical, Inc. (NASDAQ:RMTI) Analysts Just Made A Major Cut To Next Year's Estimates

How Many Rockwell Medical, Inc. (NASDAQ:RMTI) Shares Do Institutions Own?

Jan 18
How Many Rockwell Medical, Inc. (NASDAQ:RMTI) Shares Do Institutions Own?

Dosing underway in Rockwell Medical's late-stage Triferic trial in China

Jan 13

Rockwell Medical: Heavily Oversold Company With Big Potential

Jan 11

Earnings and Revenue Growth Forecasts

NasdaqCM:RMTI - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20251092N/AN/A2
12/31/2024100-1N/AN/A2
6/30/202494-5-5-5N/A
3/31/202487-9-8-8N/A
12/31/202384-9-10-9N/A
9/30/202381-9-10-10N/A
6/30/202376-12-7-7N/A
3/31/202376-13-11-11N/A
12/31/202273-19-17-17N/A
9/30/202269-25-26-26N/A
6/30/202266-29-32-32N/A
3/31/202263-32-31-31N/A
12/31/202162-33-34-34N/A
9/30/202162-32-34-33N/A
6/30/202161-32-32-31N/A
3/31/202162-31-36-36N/A
12/31/202062-31-31-30N/A
9/30/202063-30-27-26N/A
6/30/202063-30-28-28N/A
3/31/202062-33-30-28N/A
12/31/201961-34-29-27N/A
9/30/201963-36-29-28N/A
6/30/201964-33-28-26N/A
3/31/201964-35-22-21N/A
12/31/201863-32-21-20N/A
9/30/201861-32-21-19N/A
6/30/201859-32-20-19N/A
3/31/201858-27N/A-21N/A
12/31/201757-26N/A-21N/A
9/30/201756-22N/A-16N/A
6/30/201754-21N/A-18N/A
3/31/201754-20N/A-16N/A
12/31/201653-20N/A-12N/A
9/30/201654-21N/A-16N/A
6/30/201656-18N/A-13N/A
3/31/201655-16N/A-14N/A
12/31/201555-14N/A-13N/A
9/30/201556-15N/A4N/A
6/30/201555-17N/A8N/A
3/31/201555-17N/A11N/A
12/31/201454-21N/A4N/A
9/30/201454-23N/A-21N/A
6/30/201453-33N/A-31N/A
3/31/201453-41N/A-50N/A
12/31/201352-49N/A-51N/A
9/30/201351-54N/A-50N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: RMTI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).

Earnings vs Market: RMTI is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: RMTI is expected to become profitable in the next 3 years.

Revenue vs Market: RMTI's revenue (9.5% per year) is forecast to grow faster than the US market (8.7% per year).

High Growth Revenue: RMTI's revenue (9.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if RMTI's Return on Equity is forecast to be high in 3 years time


Discover growth companies